Orally available tubulin inhibitor VERU-111 enhances...

Cancer Letters 2020 / 12 Vol. 495

Orally available tubulin inhibitor VERU-111 enhances antitumor efficacy in paclitaxel-resistant lung cancer

Mahmud, Foyez, Deng, Shanshan, Chen, Hao, Miller, Duane D., Li, Wei
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
495
Journal:
Cancer Letters
DOI:
10.1016/j.canlet.2020.09.004
Date:
December, 2020
File:
PDF, 13.50 MB
2020
Conversion to is in progress
Conversion to is failed